The FDA’s Updated Approach to Wellness Tech: A Closer Look
The U.S. Food and Drug Administration (FDA) released its 2026 guidance on Low-Risk General Wellness Devices on January 6, replacing the 2019 version and bringing much-needed clarity to how wellness technologies should be designed and marketed in today’s digital health ecosystem. The document is short, but its implications stretch across fitness bands, smartwatches, health apps, […]
UAE Health-tech Platforms: How to Ensure Ongoing Compliance
Summary Upon incorporation of a HealthTech platform in the UAE, ongoing legal, regulatory and technical obligations begin immediately. HealthTech is one of the UAE’s most tightly supervised sectors, with regulators such as the Dubai Health Authority (DHA), Ministry of Health and Prevention (MOHAP) and Emirates Drug Establishment (EDE) requiring consistent compliance. Post-incorporation compliance is not […]
Federal Decree-Law No. 6 of 2025: All you need to know about the UAE’s New Banking and Insurance Law
Summary On 8 September 2025, the UAE issued Federal Decree-Law No. 6 of 2025 Regarding the Central Bank, the Regulation of Financial Institutions, their Activities, and Insurance Business (the Law). Effective 16 September 2025, the Law replaces previous frameworks and consolidates supervision under the Central Bank of the UAE (CBUAE). With a one-year transition period […]
Netflix And Paramount Battle for Warner: Part 3
When Netflix and Paramount each made their offers for Warner Bros. Discovery (WBD), they did not simply bid different prices and hope for the best. Each side constructed their own complex, multi-layered transaction embedded with termination rights, regulatory safeguards, and risk allocation mechanisms that, in many ways, matter as much as the headline dollars do. […]
Netflix And Paramount Battle for Warner: Part 2
As we covered in Part 1 of this series, Netflix announced a definitive agreement to acquire Warner Bros. Studios, HBO, HBO Max, DC Entertainment, and TNT Sports for $27.75 per share on 5 December, valuing the deal at approximately $72 billion. Three days later, Paramount launched a hostile, all-cash bid directly to shareholders at $30 […]
The EU Digital Omnibus on AI: All You Need to Know About The Proposed Amendments to the EU AI Act
Summary On 19 November 2025, the European Commission (the “Commission”) published its Digital Omnibus on AI, a legislative proposal to streamline implementation of the EU Artificial Intelligence Act (the “Act”). The proposal addresses delays in harmonized standards and guidance while adjusting compliance timelines and reducing administrative burdens. Key points: High-risk AI system compliance deadlines extended, […]
Netflix And Paramount Battle for Warner: Part 1
In this series of articles, we examine the competing proposals by Netflix and Paramount for the acquisition of Warner Bros. Discovery, unpacking not only the financial and strategic dimensions but also the antitrust and regulatory issues that will ultimately influence the fate of these deals. Overview In September 2025, Warner Bros. Discovery found itself at […]
Federal Decree Law No. 20 of 2025: All You Need to Know About The Latest Amendments to the UAE Companies Law
Summary On 1 October 2025, the UAE issued Federal Decree-Law No. (20) of 2025 (Amendment Law), introducing targeted amendments to Federal Decree-Law No. (32) of 2021 on Commercial Companies (CCL). Key points: Scope extended to foreign companies with UAE presence and clarifies free zone company operations outside designated zones Re-domiciliation framework established, allowing companies to […]
How Does the UAE Regulate Digital Health Platforms?
Summary The UAE’s healthcare and healthtech sectors operate under a multi-layered regulatory system split between federal and emirate-level authorities. Setting up a healthtech platform requires navigating jurisdictional choices, licensing requirements, and comprehensive compliance obligations including data protection, telemedicine standards, and cybersecurity measures. Key points: Three primary regulators govern healthcare: Ministry of Health and Prevention (MOHAP) […]
How is SaMD (Software as a Medical Device) Regulated in the UAE?
Summary Software as a Medical Device (SaMD) represents a rapidly growing segment of digital health innovation in the UAE. Under Federal Decree-Law No. 38 of 2024, which came into effect on January 2, 2025, SaMD is subject to comprehensive regulatory oversight by the Emirates Drug Establishment (EDE). Key points: Digital health tools that diagnose, treat, […]
